Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aldesulfon Sodium
2. Diasone
3. Sulfoxone
4. Sulfoxone, Disodium Salt
1. Aldesulfone Sodium
2. Adesulfone Sodium
3. Diasone
4. 144-75-2
5. Novotrone
6. Diasone Sodium
7. Aldapsone
8. Diamidin
9. Diazon
10. Sodium Sulfoxone
11. Sodium Aldesulphone
12. Aldesulphone Sodium
13. Diasone Sodium Enterab
14. Aldesulfone Sodium [inn]
15. Disodium (sulfonylbis(p-phenyleneimino))dimethanesulfinate
16. 57owb0q221
17. Nsc-27222
18. Aldesulfone Sodium (inn)
19. Disodium Formaldehydesulfoxylate-diaminodiphenylsulfone
20. Methanesulfinic Acid, (sulfonylbis(1,4-phenyleneimino))bis-, Disodium Salt
21. Disodium (sulfonylbis(p-phenylenimino))dimethanesulfinate
22. 4:4'-diaminodiphenylsulfone Disodium Formaldehyde Sulfoxylate
23. Aldesulfone [sodium]
24. Nsc 27222; Novotrone; Sodium Aldesulphone; Sodium Sulfoxone
25. Adesulfone Sodium [inn]
26. Aldesulfona Sodica
27. Aldesulfone Sodique
28. Aldesulfonum Natricum
29. Disodium Diformaldehydesulfoxylate
30. Aldesulfona Sodica [inn-spanish]
31. Aldesulfone Sodique [inn-french]
32. Aldesulfonum Natricum [inn-latin]
33. Ncgc00183864-01
34. Nsc 27222
35. Unii-57owb0q221
36. Ai3-23947
37. [sulfonylbis(p-phenyleneimino)]dimethanesulfinic Acid, Disodium Salt
38. Diasone Sodium (tn)
39. Disodium Formaldehyde Sulfoxylate Diamino Diphenylsulfone
40. [4-[4-(sulfinomethylamino)phenyl]sulfonylanilino]methanesulfinic Acid
41. Aniline, 4,4'-sulfonyldi-, Bis(sodium Formaldehydesulfonylate)
42. Aniline, 4,4'-sulfonyldi-, Bis(sodium Formaldehydesulfoxylate)
43. Sulfoxone Sodium [usp]
44. (sulfonylbis(p-phenyleneimino))dimethanesulfinic Acid Disodium Salt
45. Dsstox_cid_3623
46. Dsstox_rid_77116
47. Dsstox_gsid_23623
48. Schembl155722
49. Sulfoxone Sodium [mi]
50. Chembl1200580
51. Dtxsid9023623
52. Aldesulfone Sodium [mart.]
53. Aldesulfone Sodium [who-dd]
54. Ex-a3985
55. Tox21_113217
56. Akos015913824
57. Methanesulfinic Acid, (sulfonylbis(4,1-phenyleneimino))bis-, Disodium Salt
58. Methanesulfinic Acid, (sulfonylbis(p-phenyleneimino))di-, Disodium Salt
59. Sulfoxone Sodium [orange Book]
60. Cas-144-75-2
61. D02521
62. Q4713785
63. Disodium [sulfonylbis(benzene-4,1-diylimino)]dimethanesulfinate
64. Disodium;[4-[4-(sulfinatomethylamino)phenyl]sulfonylanilino]methanesulfinate
65. Methanesulfinic Acid,[sulfonylbis(4,1-phenyleneimino)]bis-,disodium Salt(9ci)
| Molecular Weight | 448.5 g/mol |
|---|---|
| Molecular Formula | C14H14N2Na2O6S3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 6 |
| Exact Mass | 447.98093826 g/mol |
| Monoisotopic Mass | 447.98093826 g/mol |
| Topological Polar Surface Area | 185 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 509 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
J - Antiinfectives for systemic use
J04 - Antimycobacterials
J04B - Drugs for treatment of lepra
J04BA - Drugs for treatment of lepra
J04BA03 - Aldesulfone sodium
ABOUT THIS PAGE
A Sulfoxone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulfoxone, including repackagers and relabelers. The FDA regulates Sulfoxone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulfoxone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulfoxone supplier is an individual or a company that provides Sulfoxone active pharmaceutical ingredient (API) or Sulfoxone finished formulations upon request. The Sulfoxone suppliers may include Sulfoxone API manufacturers, exporters, distributors and traders.
Sulfoxone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulfoxone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulfoxone GMP manufacturer or Sulfoxone GMP API supplier for your needs.
A Sulfoxone CoA (Certificate of Analysis) is a formal document that attests to Sulfoxone's compliance with Sulfoxone specifications and serves as a tool for batch-level quality control.
Sulfoxone CoA mostly includes findings from lab analyses of a specific batch. For each Sulfoxone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulfoxone may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulfoxone EP), Sulfoxone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulfoxone USP).
LOOKING FOR A SUPPLIER?
